Lifecore Biomedical, Inc. LFCR Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Lifecore Biomedical, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s total debt?
- Lifecore Biomedical, Inc. (LFCR) reported total debt of $156.93M in Q1 2026.
- How has Lifecore Biomedical, Inc.'s total debt changed year-over-year?
- Lifecore Biomedical, Inc.'s total debt increased by 1309.8% year-over-year, from $11.13M to $156.93M.
- What is the long-term trend for Lifecore Biomedical, Inc.'s total debt?
- Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s total debt has grown at a -4.0% compound annual growth rate (CAGR), from $192.4M to $156.93M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.